Slingshot members are tracking this event:
Top-Line Results on Solanezumab Phase 3 Clinical Trial in Patients with Alzheimer's Disease
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Apr 25, 2012
Don’t see a project related to the catalyst you care about?
Related Keywords Solanezumab, Alzheimer's